Barriers to efficient development of cancer therapeutics.
Schein
Philip S
PS
University of Oxford, Oxford, England. philschein@schein.us
Scheffler
Barbara
B
D000818:Animals; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration